Drug data last refreshed 4h ago · AI intelligence enriched 3w ago
RID Mousse is a topical aerosol pediculicide containing pyrethrins and piperonyl butoxide, used to treat head lice infestations. Pyrethrins are natural insecticides derived from chrysanthemum flowers that disrupt the nervous system of lice, while piperonyl butoxide enhances their efficacy. This combination product represents a non-prescription approach to a common parasitic infection affecting children and adults.
Product is in late-stage lifecycle with moderate competitive pressure (30), indicating defensive market positioning and likely smaller, specialized brand team focused on retention rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
RID Mousse offers limited career expansion opportunities given its LOE-approaching status and zero linked job postings, indicating a mature product with established processes and smaller team size. Career growth on this brand requires focus on operational excellence, market defense, and potential transition planning to line extensions or related OTC dermatology portfolios at Bayer.
Worked on RID MOUSSE at Bayer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.